Details for New Drug Application (NDA): 214420
✉ Email this page to a colleague
NDA 214420 describes POTASSIUM CITRATE, which is a drug marketed by Ut Sw Medctr, Ani Pharms, Ascent Pharms Inc, Bionpharma, Hibrow Hlthcare, Rising, Strides Pharma, Teva Pharms Usa Inc, Torrent, and Zydus Pharms, and is included in ten NDAs. It is available from thirteen suppliers. Additional details are available on the POTASSIUM CITRATE profile page.
The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and forty drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.
The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and forty drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.
Summary for 214420
| Tradename: | POTASSIUM CITRATE |
| Applicant: | Ascent Pharms Inc |
| Ingredient: | potassium citrate |
| Patents: | 0 |
Pharmacology for NDA: 214420
| Mechanism of Action | Acidifying Activity Calcium Chelating Activity |
| Physiological Effect | Decreased Coagulation Factor Activity |
Medical Subject Heading (MeSH) Categories for 214420
Suppliers and Packaging for NDA: 214420
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 214420 | ANDA | Camber Pharmaceuticals, Inc | 31722-129 | 31722-129-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-129-01) |
| POTASSIUM CITRATE | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 214420 | ANDA | Camber Pharmaceuticals, Inc | 31722-130 | 31722-130-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-130-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 5MEQ | ||||
| Approval Date: | Feb 5, 2021 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MEQ | ||||
| Approval Date: | Feb 5, 2021 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 15MEQ | ||||
| Approval Date: | Feb 5, 2021 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
